Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Diagnostica e ricerca

Mr. Robert  Guigley

Chief Commercial Officer

Mr. Kenneth D. Knight

President, Chief Executive Officer & Director

Dr. Randal W. Scott Ph.D.

Co-Founder & Chairman of the Board

Ms. Ana J. Schrank

Chief Accounting Officer & Chief Financial Officer

Mr. Thomas R. Brida

General Counsel, Chief Compliance Officer & Secretary

Dr. David B. Sholehvar M.D.

Chief Operating Officer

Ms. Hoki  Luk

Head of Investor Relations and Capital Markets

Ms. Shelly D. Guyer

Chief Sustainability Officer

Ms. Desarie  French

Chief Talent Officer

Dr. W. Michael Korn M.D.

Chief Medical Officer

Nome	Capitalizzazione di mercato
Thyrocare Technologies Limited	0M
HTG Molecular Diagnostics, Inc.	0M
Global Cord Blood Corporation	0M
ANGLE plc	0M
Diaceutics PLC	0M
Myriad Genetics, Inc.	0M
Centogene N.V.	0M
DermTech, Inc.	0M
HTG Molecular Diagnostics, Inc.	0M
SQI Diagnostics Inc.	0M

Invitae Corporation

Invitae Corporation Elenco dei concorrenti

Principali concorrenti